The report "Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030", is projected to reach USD 28.3 billion by 2030 from USD 19.9 billion in 2025, growing at a CAGR of 7.4%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506
Browse
- 608 Market Data Tables
- 86 Figures
- 582 Pages and in-depth TOC on " Infusion Pump Market - Global Forecast to 2030”
Some of the prominent key players are:
- Becton, Dickinson and Company (US),
- Baxter International Inc. (US),
- B. Braun Melsungen AG (Germany),
- Terumo Corporation (Japan),
- NIPRO (Japan),
- Fresenius Kabi (Germany),
- ICU Medical, Inc. (US). and many more.......
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Infusion Pump Market.
Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506
- Based on products, The devices segment of the infusion pump market held the largest share in 2024 because infusion pumps are widely used in hospitals, clinics, and homecare for precise and controlled drug delivery. The rise in chronic diseases, more surgical procedures, and the increasing adoption of advanced, smart, and portable pumps have further boosted demand.
- Based on type, the accessories & consumables segment accounted for a larger market share in 2024. The substantial market share attributed to infusion pump disposables is primarily linked to their critical role in ensuring safe and effective medication administration through recurrent use. This category encompasses essential components such as infusion sets, catheters, tubing, and connectors, all of which are single-use items that require regular replacement to maintain patient safety and minimize infection risk.
- Based on applications, The rapid expansion of the diabetes management segment is primarily driven by the increasing prevalence of diabetes, alongside significant technological advancements in infusion pump devices, notably insulin pumps. A key factor propelling this segment forward is the emergence of sophisticated insulin delivery systems, specifically hybrid closed-loop systems, commonly referred to as artificial pancreas devices.
- Geographically, the infusion pumps market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2024, North America emerged as the dominant player in the infusion pump market, primarily driven by substantial healthcare expenditures in the US.
Infusion pumps are medical devices used to deliver controlled amounts of fluids, such as nutrients and medications, into a patient’s body. The market growth is driven by the rising prevalence of chronic diseases such as diabetes and cancer, increasing demand for advanced drug delivery systems, and growing adoption of ambulatory and homecare settings. Furthermore, technological advancements in smart infusion systems and supportive regulatory frameworks promoting patient safety are expected to boost market expansion during the forecast period.
The market is expected to experience significant growth over the next decade, driven by increasing healthcare demands, technological progress, and the rising need for precise drug delivery systems. Infusion pumps are being adopted more widely because of their ability to deliver controlled and accurate doses, making them essential for managing chronic diseases, oncology treatments, and pain management. The move toward home healthcare, along with the integration of smart, connected pump technologies, further boosts their importance in enhancing patient safety and treatment results. With a growing global patient population and a focus on advanced care solutions, infusion pumps are poised to play a key role in modern healthcare delivery.
